Published in J Biol Chem on March 07, 1997
Molecular mechanisms of decreased smooth muscle differentiation marker expression after vascular injury. J Clin Invest (2000) 2.33
Serum response factor-dependent MicroRNAs regulate gastrointestinal smooth muscle cell phenotypes. Gastroenterology (2011) 1.79
CArG elements control smooth muscle subtype-specific expression of smooth muscle myosin in vivo. J Clin Invest (2001) 1.69
Sp1-dependent activation of KLF4 is required for PDGF-BB-induced phenotypic modulation of smooth muscle. Am J Physiol Heart Circ Physiol (2009) 1.32
Changes in the balance of phosphoinositide 3-kinase/protein kinase B (Akt) and the mitogen-activated protein kinases (ERK/p38MAPK) determine a phenotype of visceral and vascular smooth muscle cells. J Cell Biol (1999) 1.28
Influence of culture medium on smooth muscle cell differentiation from human bone marrow-derived mesenchymal stem cells. Tissue Eng Part A (2009) 1.13
Calcineurin-GATA-6 pathway is involved in smooth muscle-specific transcription. J Cell Biol (2002) 1.12
Four isoforms of serum response factor that increase or inhibit smooth-muscle-specific promoter activity. Biochem J (2000) 0.99
Cigarette smoke modulates vascular smooth muscle phenotype: implications for carotid and cerebrovascular disease. PLoS One (2013) 0.88
PKA-dependent phosphorylation of serum response factor inhibits smooth muscle-specific gene expression. Arterioscler Thromb Vasc Biol (2009) 0.83
A novel combination of promoter and enhancers increases transgene expression in vascular smooth muscle cells in vitro and coronary arteries in vivo after adenovirus-mediated gene transfer. Gene Ther (2003) 0.82
Laser microdissection-based analysis of mRNA expression in human coronary arteries with intimal thickening. J Histochem Cytochem (2004) 0.81
Genome-wide microarray analyses identify the protein C receptor as a novel calcineurin/nuclear factor of activated T cells-dependent gene in vascular smooth muscle cell phenotypic modulation. Arterioscler Thromb Vasc Biol (2011) 0.75
DNA methylation of a GC repressor element in the smooth muscle myosin heavy chain promoter facilitates binding of the Notch-associated transcription factor, RBPJ/CSL1. Arterioscler Thromb Vasc Biol (2014) 0.75
Regulation of actin dynamics by WNT-5A: implications for human airway smooth muscle contraction. Sci Rep (2016) 0.75
Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res (1988) 3.71
Expression of smooth muscle-specific alpha-isoactin in cultured vascular smooth muscle cells: relationship between growth and cytodifferentiation. J Cell Biol (1986) 3.00
L-type voltage-gated Ca2+ channels modulate expression of smooth muscle differentiation marker genes via a rho kinase/myocardin/SRF-dependent mechanism. Circ Res (2004) 2.55
Positive- and negative-acting Kruppel-like transcription factors bind a transforming growth factor beta control element required for expression of the smooth muscle cell differentiation marker SM22alpha in vivo. J Biol Chem (2000) 2.54
Molecular mechanisms of decreased smooth muscle differentiation marker expression after vascular injury. J Clin Invest (2000) 2.33
Development of a smooth muscle-targeted cre recombinase mouse reveals novel insights regarding smooth muscle myosin heavy chain promoter regulation. Circ Res (2000) 2.30
Smooth muscle differentiation marker gene expression is regulated by RhoA-mediated actin polymerization. J Biol Chem (2001) 2.28
Carbohydrate moieties of glycoproteins. A re-evaluation of their function. Biochim Biophys Acta (1982) 2.27
Knowing for the sake of knowing: the value of prognostic information. Med Decis Making (1990) 2.27
A transforming growth factor beta (TGFbeta) control element drives TGFbeta-induced stimulation of smooth muscle alpha-actin gene expression in concert with two CArG elements. J Biol Chem (1997) 2.26
Regulation of smooth muscle alpha-actin expression in vivo is dependent on CArG elements within the 5' and first intron promoter regions. Circ Res (1999) 2.20
The inheritance of mitochondrial DNA heteroplasmy: random drift, selection or both? Trends Genet (2000) 2.19
Torcetrapib-induced blood pressure elevation is independent of CETP inhibition and is accompanied by increased circulating levels of aldosterone. Br J Pharmacol (2008) 2.13
Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor. J Clin Invest (1993) 2.11
BBID: the biological biochemical image database. Bioinformatics (2000) 2.07
Cognitive processes and the decisions of some parents to forego pertussis vaccination for their children. J Clin Epidemiol (1996) 2.04
Making sense out of utilization data. Med Care (1975) 1.98
A microplaque reduction assay for human and mouse interferon. Can J Microbiol (1975) 1.95
Reporting the results of cystic fibrosis carrier screening. Am J Obstet Gynecol (1993) 1.78
A G/C element mediates repression of the SM22alpha promoter within phenotypically modulated smooth muscle cells in experimental atherosclerosis. Circ Res (2004) 1.76
Expression of smooth muscle and nonmuscle myosin heavy chains in cultured vascular smooth muscle cells. J Biol Chem (1986) 1.74
CArG elements control smooth muscle subtype-specific expression of smooth muscle myosin in vivo. J Clin Invest (2001) 1.69
LPP expression during in vitro smooth muscle differentiation and stent-induced vascular injury. Circ Res (2006) 1.65
Alterations in vascular smooth muscle mass in the spontaneously hypertensive rat. Role of cellular hypertrophy, hyperploidy, and hyperplasia. Circ Res (1982) 1.64
Outcome bias in decision evaluation. J Pers Soc Psychol (1988) 1.58
Smooth muscle-specific expression of the smooth muscle myosin heavy chain gene in transgenic mice requires 5'-flanking and first intronic DNA sequence. Circ Res (1998) 1.55
Smooth muscle cell hypertrophy versus hyperplasia in hypertension. Proc Natl Acad Sci U S A (1981) 1.51
Selective expression of an endogenous inhibitor of FAK regulates proliferation and migration of vascular smooth muscle cells. Mol Cell Biol (2001) 1.49
Omission bias and pertussis vaccination. Med Decis Making (1994) 1.48
Assessing physicians' estimates of the probability of coronary artery disease: the influence of patient characteristics. Med Decis Making (1992) 1.42
The illusion of deterministic rules. Ann Intern Med (1997) 1.39
Ophthalmic cyclosporine in equine keratitis and keratouveitis: 11 cases. Equine Vet J (1995) 1.38
Oligosaccharide modification by swainsonine treatment inhibits pulmonary colonization by B16-F10 murine melanoma cells. Proc Natl Acad Sci U S A (1986) 1.37
Interaction of CArG elements and a GC-rich repressor element in transcriptional regulation of the smooth muscle myosin heavy chain gene in vascular smooth muscle cells. J Biol Chem (1997) 1.36
Similarities and differences in smooth muscle alpha-actin induction by TGF-beta in smooth muscle versus non-smooth muscle cells. Arterioscler Thromb Vasc Biol (1999) 1.34
Development of the aortic vessel wall as defined by vascular smooth muscle and extracellular matrix markers. Dev Biol (1996) 1.34
Patient compliance with antihypertensive medication. Am J Public Health (1980) 1.34
Why some health policies don't make sense at the bedside. Ann Intern Med (1995) 1.30
Factors affecting the use of physician services in a rural community. Am J Public Health (1976) 1.29
The smooth muscle alpha-actin gene promoter is differentially regulated in smooth muscle versus non-smooth muscle cells. J Biol Chem (1995) 1.29
Platelet-derived growth factor-BB-induced suppression of smooth muscle cell differentiation. Circ Res (1992) 1.27
Smooth muscle alpha-actin CArG elements coordinate formation of a smooth muscle cell-selective, serum response factor-containing activation complex. Circ Res (2000) 1.26
Vascular smooth muscle cell hypertrophy and hyperploidy in the Goldblatt hypertensive rat. Circ Res (1983) 1.23
The potential importance of swainsonine in therapy for cancers and immunology. Pharmacol Ther (1991) 1.23
Smooth muscle of telokin-deficient mice exhibits increased sensitivity to Ca2+ and decreased cGMP-induced relaxation. Proc Natl Acad Sci U S A (2006) 1.22
Osteoarthrosis in guinea pigs: histopathologic and scanning electron microscopic features. Lab Anim Sci (1989) 1.21
Angiotensin II-induced mitogenesis of spontaneously hypertensive rat-derived cultured smooth muscle cells is dependent on autocrine production of transforming growth factor-beta. Circ Res (1992) 1.21
Reversible permeabilization. A novel technique for the intracellular introduction of antisense oligodeoxynucleotides into intact smooth muscle. Circ Res (1995) 1.20
Elements of the smooth muscle alpha-actin promoter required in cis for transcriptional activation in smooth muscle. Evidence for cell type-specific regulation. J Biol Chem (1992) 1.20
Angiotensin II-induced stimulation of smooth muscle alpha-actin expression by serum response factor and the homeodomain transcription factor MHox. Circ Res (1997) 1.16
Myosin light chain kinase knockout. J Muscle Res Cell Motil (2004) 1.16
Electron microscopy of fibers and discs of hemoglobin S having sixfold symmetry. Proc Natl Acad Sci U S A (1977) 1.16
Platelet-derived growth factor regulates actin isoform expression and growth state in cultured rat aortic smooth muscle cells. J Cell Physiol (1990) 1.14
Cell cycle versus density dependence of smooth muscle alpha actin expression in cultured rat aortic smooth muscle cells. J Cell Biol (1988) 1.13
Inhibition of experimental metastasis by castanospermine in mice: blockage of two distinct stages of tumor colonization by oligosaccharide processing inhibitors. Cancer Res (1986) 1.12
Platelet-derived growth factor-induced destabilization of smooth muscle alpha-actin mRNA. J Cell Physiol (1990) 1.09
Immunohistochemical identification of arteriolar development using markers of smooth muscle differentiation. Evidence that capillary arterialization proceeds from terminal arterioles. Circ Res (1994) 1.07
Influence of blood pressure on development of aortic medial smooth muscle hypertrophy in spontaneously hypertensive rats. Hypertension (1987) 1.06
Developmental changes in isoactin expression in rat aortic smooth muscle cells in vivo. Relationship between growth and cytodifferentiation. J Biol Chem (1986) 1.06
Analysis of capacity decisions for progressive patient care hospital facilities. Health Serv Res (1980) 1.05
Function of the carbohydrate moieties of glycoproteins. J Cell Biochem (1982) 1.04
Hyperplastic growth response of vascular smooth muscle cells following induction of acute hypertension in rats by aortic coarctation. Circ Res (1985) 1.04
A stochastic service network model with application to hospital facilities. Oper Res (1981) 1.04
The use of an information system for community health services planning and management. Med Care (1975) 1.03
Phosphorylation of the rRNA transcription factor upstream binding factor promotes its association with TATA binding protein. Proc Natl Acad Sci U S A (1998) 1.02
Conditional mouse models to study developmental and pathophysiological gene function in muscle. Handb Exp Pharmacol (2007) 1.00
Differential effects of antihypertensive drug therapy on vascular smooth muscle cell hypertrophy, hyperploidy, and hyperplasia in the spontaneously hypertensive rat. Circ Res (1985) 1.00
Determinants of priority for risk reduction: the role of worry. Risk Anal (2000) 0.99
Differential effect of platelet-derived growth factor- versus serum-induced growth on smooth muscle alpha-actin and nonmuscle beta-actin mRNA expression in cultured rat aortic smooth muscle cells. J Biol Chem (1989) 0.99
TGF-beta promotes proliferation of cultured SMC via both PDGF-AA-dependent and PDGF-AA-independent mechanisms. J Clin Invest (1994) 0.99
Derived thresholds. Determining the diagnostic probabilities at which clinicians initiate testing and treatment. Med Decis Making (1983) 0.99
The smooth muscle myosin heavy chain gene exhibits smooth muscle subtype-selective modular regulation in vivo. J Biol Chem (2001) 0.99
Evidence for endothelium-derived relaxing factor in cultured cells. Hypertension (1985) 0.98
Angiotensin II-induced hypertrophy of rat vascular smooth muscle is associated with increased 18 S rRNA synthesis and phosphorylation of the rRNA transcription factor, upstream binding factor. J Biol Chem (1995) 0.96
Macrophages as regulators of immune responses against tumors. Adv Exp Med Biol (1979) 0.96
Differential effects of CTLA-4 substitutions on the binding of human CD80 (B7-1) and CD86 (B7-2). J Immunol (1996) 0.96
Thrombin and vascular smooth muscle cell proliferation: implications for atherosclerosis and restenosis. Semin Thromb Hemost (1996) 0.95
The public's attitudes toward incentives for organ donation. Transplant Proc (1999) 0.95
Vancomycin-induced release of histamine from rat peritoneal mast cells and a rat basophil cell line (RBL-1). Agents Actions (1991) 0.94
The relationship between erythropoietin-dependent cellular differentiation and colony-forming ability in prenatal haemopoietic tissues. J Embryol Exp Morphol (1975) 0.94
Measuring the economic impact of perioperative total parenteral nutrition: principles and design. Am J Clin Nutr (1988) 0.93
Mechanism of enlargement of major cerebral collateral arteries in rabbits. Stroke (1991) 0.92
Early histopathologic and ultrastructural alterations in femorotibial joints of partial medial meniscectomized guinea pigs. Vet Pathol (1987) 0.92
Promoting healthy diets and active lives to hard-to-reach groups: market research study. Public Health Rep (1990) 0.92
Health insurance under competition: would people choose what is expected? Inquiry (1984) 0.91
All-trans-retinoic acid limits restenosis after balloon angioplasty in the focally atherosclerotic rabbit : a favorable effect on vessel remodeling. Arterioscler Thromb Vasc Biol (2000) 0.91
Public preferences for prevention versus cure: what if an ounce of prevention is worth only an ounce of cure? Med Decis Making (1998) 0.91
Reproduction, mastitis, and body condition of seasonally calved Holstein and Jersey cows in confinement or pasture systems. J Dairy Sci (2002) 0.89
Hepatic peroxisomal changes induced by a tetrazole-substituted alkoxyacetophenone in rats and comparison with other species. Toxicol Appl Pharmacol (1986) 0.89
Augmentation of murine natural killer cell activity by swainsonine, a new antimetastatic immunomodulator. Cancer Res (1988) 0.88
Polyploid nuclei in human artery wall smooth muscle cells. Proc Natl Acad Sci U S A (1983) 0.87
Two MCAT elements of the SM alpha-actin promoter function differentially in SM vs. non-SM cells. Am J Physiol (1998) 0.87
Activated alpha 2-macroglobulin and transforming growth factor-beta 1 induce a synergistic smooth muscle cell proliferative response. J Biol Chem (1993) 0.87